Search the Newsreel

Fabrinet (FN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

The market expects Fabrinet (FN) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence …

CYTOKINETICS, INCORPORATED : LEERINK PARTNERS RAISES TARGET PRICE TO $103 FROM $100

LEERINK PARTNERS has increased its target price for CYTOKINETICS, INCORPORATED (CYTK.O) from $100 to $103. The article is a brief financial news update from Reuters, indicating a positive analyst sentiment towards the company. It notes that the content reflects only the author's opinion and …

Vista Investment Partners LLC Increases Holdings in Fortinet, Inc. $FTNT

Vista Investment Partners LLC significantly increased its stake in Fortinet, Inc. by 53.1% in the second quarter, now owning 49,058 shares valued at approximately $7.5 million. This increase makes Fortinet the 11th largest holding in Vista Investment Partners' portfolio. The cybersecurity company recently reported …

Royal Bank Of Canada Issues Positive Forecast for QinetiQ Group (LON:QQ) Stock Price

Hennion & Walsh Asset Management Inc. Trims Stake in Fortinet, Inc. $FTNT

Hennion & Walsh Asset Management Inc. reduced its stake in Fortinet, Inc. by 16.4% in the second quarter, selling 6,889 shares and holding 35,134 shares valued at $5.4 million. Despite strong quarterly earnings where Fortinet beat estimates, insider selling activity totaling $69.5 million over …

Fabrinet (FN) to Release Quarterly Earnings on Monday

Kinetic Development Expects Up to 40% Rise in Interim Profit; Shares Jump 9%

Kinetic Development Forecasts Up to 40% Profit Surge on Stronger Coal Prices and Cost Cuts

First Trust Advisors LP Raises Stake in Crinetics Pharmaceuticals, Inc. $CRNX

First Trust Advisors LP increased its stake in Crinetics Pharmaceuticals (CRNX) by 54.9% in the first quarter, now holding 51,365 shares valued at $1.87 million. Despite insider stock sales, the company reported strong Q1 earnings, beating revenue estimates by 2336.9% year-over-year. Analysts have a …

Fortinet Inc (FTNT) Stock News Today

This article provides a list of recent news updates regarding Fortinet Inc (FTNT) stock performance from TradingKey. It details several instances of the stock moving up or down by significant percentages on specific dates, offering a historical overview of its short-term volatility. The updates …

Cytokinetics, Incorporated (CYTK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Cytokinetics, Incorporated (NASDAQ:CYTK) on behalf of investors who purchased securities before December 27, 2023. The investigation seeks to determine if the company or its officers engaged in corporate wrongdoing. The law firm is encouraging …

Is Fortinet (FTNT) Fully Valued On Its Raised 2026 Revenue Guidance?

Kinetik Holdings Inc. $KNTK Shares Sold by Pacer Advisors Inc.

Birchbrook Inc. Trims Stock Position in Fortinet, Inc. $FTNT

Birchbrook Inc. significantly reduced its stake in Fortinet, Inc. by 48.6% in the second quarter, selling 7,709 shares and retaining 8,161 shares valued at $1,254,000. Despite this, other institutional investors have increased their holdings in Fortinet, with hedge funds and institutional investors collectively owning …

Intel Secures Key Deal with Fortinet for Cybersecurity Chips

Intel's foundry business has secured a significant deal with Fortinet to manufacture its next-generation Security Processor 6, marking Intel's entry into the cybersecurity chip sector. This partnership reduces Fortinet's reliance on TSMC, challenges TSMC's market dominance, and could attract more clients to Intel's foundry. …

Crinetics Pharmaceuticals Inc (CRNX) Earnings Forecast: Future EPS & Revenue Growth Estimates

Did TriNet’s Higher-Earnings-But-Lower-Revenue Quarter Just Shift TriNet Group’s (TNET) Investment Narrative?

TriNet Group (TNET) reported higher net income and diluted EPS in Q2 2026 despite lower revenue, leading to raised full-year guidance for both revenue and EPS. This shift suggests stronger profitability expectations and management confidence, reinforced by dividend increases. However, the investment narrative still …

Fortinet (FTNT) Lifted 2026 Guidance, Is The Stock Now Too Expensive?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Fortinet (FTNT) drew fresh investor attention after reporting second quarter 2026 results and issuing new guidance, including a full year 2026 revenue outlook …

Cytokinetics (NASDAQ:CYTK) Issues Quarterly Earnings Results, Beats Estimates By $0.13 EPS

Kinetik Q2 Earnings Call Highlights

Key Points Interested in Kinetik Holdings Inc.? Here are five stocks we like better. Kinetik reported record second-quarter results, including $281 million in Adjusted EBITDA, $195 million in distributable cash flow and $105 million in free cash flow. Midstream Logistics EBITDA increased 35% year …

Jim Cramer Favors Fortinet (FTNT) Alongside CrowdStrike (CRWD) and Palo Alto (PANW)

During the lightning round on the August 5 episode of CNBC's Mad Money, a caller asked a question regarding Fortinet, Inc. (NASDAQ:FTNT). and Cramer responded: Okay, we just had a little kind of a discussion. Fortinet's good, by the way. We had a little …

Cytokinetics (CYTK) Stock Looks Near Fair Value Despite UK MYQORZO Approval

Cytokinetics (CYTK) stock has shown strong returns over five years, but its current valuation suggests it's neither a clear bargain nor obviously overvalued. Despite recent UK approval for MYQORZO, the stock's high price-to-book ratio is not a reliable indicator due to the company's development-heavy …

Will Kinetik’s Q2 2026 Earnings Beat and Revenue Surge Change Kinetik Holdings' (KNTK) Narrative?

Fabrinet $FN Shares Acquired by Quantinno Capital Management LP

Quantinno Capital Management LP significantly increased its stake in Fabrinet (NYSE:FN) by 130.8% in the first quarter, now owning 7,039 shares valued at $3.67 million. Institutional investors collectively hold 97.38% of the company's stock. Fabrinet, trading at $561.84 with a market cap of $20.13 …

Beacon Investment Advisory Services Inc. Sells 10,085 Shares of Fortinet, Inc. $FTNT

Beacon Investment Advisory Services Inc. decreased its stake in Fortinet, Inc. (NASDAQ:FTNT) by 4.2% in the second quarter, selling 10,085 shares and retaining 231,189 shares valued at $35.5 million. Fortinet, a multinational cybersecurity company, has a consensus "Hold" rating from analysts with a target …

Wall Street Zen Downgrades Cytokinetics (NASDAQ:CYTK) to Sell

Wall Street Zen downgraded Cytokinetics (NASDAQ:CYTK) to a "sell" rating from "hold," despite the broader analyst consensus remaining a "Moderate Buy." This downgrade follows the biopharmaceutical company's quarterly results, which saw revenue decline 57.1% year-over-year and substantial losses, although reported revenue and EPS still …

Fortinet (FTNT) Stock Could Be 12% Overvalued On Raised 2026 Outlook

Kinetik (NYSE:KNTK) Stock Rating Upgraded by Wall Street Zen

Amundi Purchases 5,299 Shares of Fabrinet $FN

Amundi increased its stake in Fabrinet (NYSE:FN) by 301.1% in the first quarter, acquiring 5,299 additional shares, bringing its total holdings to 7,059 shares valued at $3.68 million. Fabrinet reported strong quarterly earnings with an EPS of $3.72 and revenue of $1.21 billion, surpassing …

Kinetik Holdings director ISQ Global Fund II GP LLC sells $13.3m shares

ISQ Global Fund II GP LLC, a director and 10% owner of Kinetik Holdings Inc. (KNTK), sold approximately $13.3 million worth of Class A Common Stock between August 3 and August 7, 2026, at prices ranging from $50.0416 to $51.0219 per share. These sales …

Kinetik Holdings Inc. (NYSE: KNTK) insiders sell 264K shares near $50

Entities associated with I Squared Capital, identified as ten percent owners of Kinetik Holdings Inc. (NYSE: KNTK), indirectly sold a total of 264,074 shares of Class A Common Stock between August 3 and August 7, 2026. The sales were conducted through Buzzard Midstream LLC …

Kinetik Holdings (NYSE: KNTK) plans sale of 264,074 Class A shares via Goldman Sachs

Kinetik Holdings Inc. (NYSE: KNTK) has filed a Form 144 indicating a planned sale of 264,074 Class A Common Stock shares through Goldman Sachs & Co. LLC on or after August 3, 2026. These shares, valued at approximately $12.99 million, were acquired on April …

Citizens raises Cytokinetics stock price target on strong launch

Citizens has raised its price target for Cytokinetics (NASDAQ:CYTK) to $110 from $105, maintaining a Market Outperform rating, citing the strong launch of MYQORZO and ongoing pipeline development. The company's stock has surged 131% over the past year, currently trading at $81.37, and its …

Crinetics Pharmaceuticals (NASDAQ: CRNX) sees 1.4% stake reported by FMR LLC

FMR LLC and Abigail P. Johnson have reported an amended passive investment disclosure for Crinetics Pharmaceuticals (CRNX) via a Schedule 13G/A filing. FMR LLC holds beneficial ownership of 1,439,890.88 shares, representing 1.4% of the common stock outstanding, with nearly all shares holding sole voting …

Crinetics Pharmaceuticals, Inc. $CRNX Shares Bought by Glenmede Trust Co. NA

Glenmede Trust Co. NA increased its stake in Crinetics Pharmaceuticals (NASDAQ:CRNX) by 72.6% in the first quarter, now holding 29,245 shares valued at $1.06 million. Despite some insider selling, institutional investors own 98.51% of the company. Crinetics Pharmaceuticals reported better-than-expected Q1 earnings with a …

Cytokinetics (CYTK) Stock Sees MYQORZO Momentum Collide With Mounting Losses

Cytokinetics (CYTK) saw its shares fall 6% despite early success with its new cardiomyopathy drug, MYQORZO, which generated $25.3 million in net product revenue. The company posted a significant net loss of $198.8 million in Q2 2026, widening from the previous year, as heavy …